- Home
- FDMT vs LIEN Comparison
FDMT vs LIEN Comparison
Compare FDMT & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- LIEN
- Stock Information
- Founded
- FDMT 2013
- LIEN 2021
- Country
- FDMT United States
- LIEN United States
- Employees
- FDMT N/A
- LIEN N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- LIEN
- Sector
- FDMT Health Care
- LIEN
- Exchange
- FDMT Nasdaq
- LIEN NYSE
- Market Cap
- FDMT 268.6M
- LIEN 278.9M
- IPO Year
- FDMT 2020
- LIEN 2022
- Fundamental
- Price
- FDMT $4.64
- LIEN $12.43
- Analyst Decision
- FDMT Buy
- LIEN
- Analyst Count
- FDMT 10
- LIEN 0
- Target Price
- FDMT $36.33
- LIEN N/A
- AVG Volume (30 Days)
- FDMT 957.1K
- LIEN 5.0K
- Earning Date
- FDMT 03-03-2025
- LIEN 03-26-2025
- Dividend Yield
- FDMT N/A
- LIEN 11.13%
- EPS Growth
- FDMT N/A
- LIEN N/A
- EPS
- FDMT N/A
- LIEN 0.67
- Revenue
- FDMT $17,000.00
- LIEN $12,681,914.00
- Revenue This Year
- FDMT N/A
- LIEN $71.81
- Revenue Next Year
- FDMT $159.36
- LIEN $113.93
- P/E Ratio
- FDMT N/A
- LIEN $18.32
- Revenue Growth
- FDMT N/A
- LIEN 22.94
- 52 Week Low
- FDMT $4.41
- LIEN $8.38
- 52 Week High
- FDMT $36.25
- LIEN $13.38
- Technical
- Relative Strength Index (RSI)
- FDMT 40.01
- LIEN N/A
- Support Level
- FDMT $4.41
- LIEN N/A
- Resistance Level
- FDMT $5.42
- LIEN N/A
- Average True Range (ATR)
- FDMT 0.48
- LIEN 0.00
- MACD
- FDMT -0.05
- LIEN 0.00
- Stochastic Oscillator
- FDMT 9.38
- LIEN 0.00
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.